PSC is an idiopathic condition of nonmalignant, nonbacterial, chronic inflammatory fibrosis, with destruction of intrahepatic and extrahepatic bile ducts.
PSC most commonly occurs in young men, often in association with ulcerative colitis.
The clinical spectrum of PSC is varied. Asymptomatic patients can have abnormal liver enzymes (typically alkaline phosphatase), or people can have recurring episodes of fever, chills, abdominal pain, and jaundice.
Diagnosis is made by ERCP or MRCP, showing characteristic beading of the bile ducts.
Stricturing of intra or extrahepatic ducts leads to chloestasis.
No proven therapy works, though ursodeoxycholic acid and methotrexate are being used in some centers.
Dominant biliary strictures can be opened using ERCP.
Prophylactic antibiotics can be given to prevent recurrent cholangitis, and fat-soluble vitamins can be given.
Most people with advanced PSC eventually develop end-stage liver disease, and about one-third will develop cholangiocarcinoma.